SEP 05, 2016 8:23 AM PDT

Just another reason to avoid nicotine: tissue damage

WRITTEN BY: Kara Marker
A new study from Umea University in Sweden provides yet another reason for people to refrain from smoking. They found that nicotine, the very substance that makes tobacco products so addictive, is directly linked to inflammatory diseases, including chronic obstructive lung disease (COPD) and many others.
Credit: Ava Hosseinzadeh, UmeƄ University
While the right amount of inflammation protects humans from invading pathogens like bacteria and viruses, overstimulation of certain immune cells can cause excessive and dangerous inflammation. In the case of nicotine exposure, whether directly from tobacco products or by way of second-hand smoke, the drug drug activates a type of lymphocyte to release pro-inflammatory and potentially toxic compounds.

The most abundant white blood cell in the bloodstream, the neutrophil, is responsible for releasing certain chemicals at the “scene of the crime,” AKA the site of infection. Neutrophils release reactive oxygen species (ROS) and DNA Fibers called neutrophil extracellular traps (NETs) to kill pathogens. However, ROS and NETs can also be harmful to human tissue.

Nicotine causes damage to the human body by triggering neutrophils to release ROS and NETs via an acetylcholine receptor on the surface of neutrophils. A protein kinase enzyme called Akt also helps to transmit the signal from nicotine into the neutrophil. ROS production and NET release without a pathogenic cause causes tissue damage, leading to inflammatory diseases like small vessel vasculitis, arthritis, and even cancer.

Constantin Urban, associate professor and project leader at Umea University, said that the research “should be seen as one more convincing argument to quit nicotine usage in any form.” Urban and the rest of the team from Umea showed for the first time that nicotine triggers NET release.

In the future, the researchers plan to show just how much NETs animal and human neutrophils are capable of releasing in response to stimulation in the presence of nicotine. They are hopeful that their findings will eventually lead to new anti-inflammatory therapies for diseases related to tobacco usage. 

Their study was recently published in the Journal of Leukocyte Biology
 


Source: Umea University Laboratory for Molecular Infection Medicine Sweden (MIMS)
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
MAR 04, 2021
Immunology
Why Do We Need Two Shots of the COVID Vaccine?
MAR 04, 2021
Why Do We Need Two Shots of the COVID Vaccine?
Unlike social distancing, mask-wearing, and hand hygiene, vaccines are our best bet as a long-term solution to protectin ...
APR 13, 2021
Immunology
Food-borne Fungus Impedes Gut Healing
APR 13, 2021
Food-borne Fungus Impedes Gut Healing
In a recent study, researchers discovered that a fungus present in cheese, processed meats, beer, and other fermented fo ...
APR 22, 2021
Immunology
Healthy, Young People Are Getting Reinfected With COVID
APR 22, 2021
Healthy, Young People Are Getting Reinfected With COVID
If you’re young and healthy and you’ve had COVID, your body will produce protective antibodies that guard yo ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 16, 2021
Immunology
Researchers Identify a Novel COVID Therapeutic Target and Mortality Predictor
JUN 16, 2021
Researchers Identify a Novel COVID Therapeutic Target and Mortality Predictor
Researchers at King’s College London have discovered a new antiviral target to combat COVID-19: the galectin-3-bin ...
Loading Comments...